Suppr超能文献

择期开始腹膜透析后细胞外水化状态增加。

Increase in Extracellular Hydration Status After Initiating Peritoneal Dialysis Electively.

作者信息

Panorchan Kwanpeemai, Davenport Andrew

机构信息

UCL Centre for Nephrology, Royal Free Hospital, University College London Medical School, London, UK.

UCL Centre for Nephrology, Royal Free Hospital, University College London Medical School, London, UK

出版信息

Perit Dial Int. 2017 May-Jun;37(3):338-340. doi: 10.3747/pdi.2016.00213.

Abstract

Renal replacement therapy is designed to treat uremic symptoms and correct hypervolemia. We hypothesized that starting peritoneal dialysis (PD) should reduce overhydration, and we measured body composition and hydration status using bioimpedance in PD patients prior to training and then at the first assessment of peritoneal membrane function. We studied 100 consecutive patients with a planned start to PD, without peritoneal infections or mechanical catheter problems, mean age 54.7 ± 17.1 years, 57% male and 25% diabetic. Extracellular water (ECW) overhydration increased from -0.06 (-1.21 to 0.97) L to 0.96 (0.50 to 3.01) L, < 0.001. Fat mass increased from 22.7 ± 11.1 to 23.7 ± 11.3 kg, = 0.007). The change in ECW/total body water (TBW) was associated with age (β 0.065, < 0.001), increasing comorbidity (β 1.107, = 0.005), faster peritoneal protein transport (β 1.84, < 0.04), and negatively with serum albumin (β -0.208, < 0.001), and residual renal function (β -0.725, = 0.026). Patients who had an increase in ECW/TBW had higher C-reactive protein (CRP) both before starting (16.8 ± 24.1 vs 7.7 ± 18.9 mg/L), and when established on PD (15.0 ± 31.8 vs 4.6 ± 5.1 mg/L), < 0.05. Rather than a reduction in ECW hydration status, overhydration increased after starting PD. This was greater for older more comorbid patients and those with an inflammatory milieu and lower residual renal function. These factors should be considered when deciding upon initial PD prescriptions to limit ECW overhydration before information on peritoneal membrane function becomes available.

摘要

肾脏替代疗法旨在治疗尿毒症症状并纠正血容量过多。我们假设开始腹膜透析(PD)应能减轻水过多,并且我们在培训前以及首次评估腹膜功能时,使用生物电阻抗测量了PD患者的身体成分和水合状态。我们研究了100例计划开始进行PD的连续患者,这些患者无腹膜感染或机械导管问题,平均年龄54.7±17.1岁,男性占57%,糖尿病患者占25%。细胞外液(ECW)水过多从-0.06(-1.21至0.97)L增加至0.96(0.50至3.01)L,P<0.001。脂肪量从22.7±11.1增加至23.7±11.3kg,P = 0.007)。ECW/总体水(TBW)的变化与年龄(β0.065,P<0.001)、合并症增加(β1.107,P = 0.005)、腹膜蛋白转运加快(β1.84,P<0.04)呈正相关,与血清白蛋白(β -0.208,P<0.001)和残余肾功能(β -0.725,P = 0.026)呈负相关。ECW/TBW增加的患者在开始透析前(16.8±24.1 vs 7.7±18.9mg/L)和确定进行PD时(15.0±31.8 vs 4.6±5.1mg/L)的C反应蛋白(CRP)均较高,P<0.05。开始PD后,水过多状况非但没有减轻,反而增加了。对于年龄较大、合并症较多以及有炎症环境和残余肾功能较低的患者,这种情况更为明显。在获得腹膜功能信息之前,决定初始PD处方以限制ECW水过多时,应考虑这些因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验